PF251 GILTERITINIB PROLONGS SURVIVAL IN PATIENTS WITH FLT3‐MUTATED RELAPSED/REFRACTORY AML WHO HAVE COMMON AML CO‐MUTATIONS OR A HIGH FLT3‐ITD ALLELIC RATIO | Publicación